Exploring Predictive Biomarkers for Drug-Induced Pulmonary Toxicities – Enhertu Experience
Time: 11:15 am
day: Scientific Program Day One
Details:
- Overviewing biomarkers for drug induced pulmonary toxicities
- Defining responsibility by discussing who should lead clinical sample-based translational research for safety?
- Addressing the gap between tox teams (preclinical) and clinical safety teams
- Case study: Interstitial lung disease (ILD) concerns in HER2-targeted ADCs – how are biomarkers in blood helping refine prediction and how can we monitor and treat ADC toxicities
